Pindolol

Overview

Pindolol is a first generation non-selective beta blocker used in the treatment of hypertension. Early research into the use of pindolol found it had chronotropic effects, and so further investigation focused on the treatment of arrhythmia. Research into pindolol's use in the treatment of hypertension began in the early 1970s. Pindolol was granted FDA approval on 3 September 1982.

Indication

Pindolol is indicated in the management of hypertension. In Canada, it is also indicated in the prophylaxis of angina.

Associated Conditions

Angina Pectoris
Atrial Fibrillation
Depression
Hypertension

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate	2013/09/25	NCT01950520	Phase 2	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand Preparations	2011/07/22	NCT01400165	Phase 1	UNKNOWN	University of Ottawa
EScitalopram PIndolol ONset of Action	2010/10/13	NCT01219686	Phase 2	Terminated	Markus KOSEL
Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder	2009/07/02	NCT00931775	Phase 2	Completed	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)	2009/05/08	NCT00895804	Phase 1	Completed	University Hospital, Basel, Switzerland
Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris	2007/01/22	NCT00424801	Not Applicable	Terminated	University of Aarhus
Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression	2005/09/12	NCT00159146	Not Applicable	Terminated	Hillerod Hospital, Denmark

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Pindolol	Zydus Pharmaceuticals USA Inc.	70710-1063	ORAL	5 mg in 1 1	11/10/2022
Pindolol	Marlex Pharmaceuticals, Inc.	10135-744	ORAL	10 mg in 1 1	7/6/2023
Pindolol	Carilion Materials Management	68151-3005	ORAL	10 mg in 1 1	8/1/2010
Pindolol	Carilion Materials Management	68151-1320	ORAL	5 mg in 1 1	11/29/2016
Pindolol	Zydus Lifesciences Limited	70771-1135	ORAL	10 mg in 1 1	10/13/2022
Pindolol	Zydus Lifesciences Limited	70771-1134	ORAL	5 mg in 1 1	10/13/2022
Pindolol	Mylan Pharmaceuticals Inc.	0378-0127	ORAL	10 mg in 1 1	11/29/2016
Pindolol	Marlex Pharmaceuticals, Inc.	10135-743	ORAL	5 mg in 1 1	7/6/2023
Pindolol	Nostrum Laboratories, Inc.	29033-028	ORAL	5 mg in 1 1	12/17/2018
Pindolol	Zydus Pharmaceuticals USA Inc.	70710-1064	ORAL	10 mg in 1 1	11/10/2022

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
PMS-PINDOLOL	Pharmascience Inc	02231539	Tablet - Oral	15 MG	5/28/1998
APO-PINDOL TAB 5MG	Apotex Inc	00755877	Tablet - Oral	5 MG	12/31/1988
DOM-PINDOLOL	dominion pharmacal	02238046	Tablet - Oral	10 MG	9/17/1998
PMS-PINDOLOL	Pharmascience Inc	02231537	Tablet - Oral	10 MG	5/28/1998
SYN-PINDOLOL TAB 10MG	syncare pharmaceutical inc.	00818593	Tablet - Oral	10 MG / TAB	12/31/1989
TEVA-PINDOLOL	teva canada limited	00869015	Tablet - Oral	10 MG	12/31/1990
PINDOLOL-10 TAB 10MG	PRO DOC LIMITEE	00828424	Tablet - Oral	10 MG	12/31/1989
SANDOZ-PINDOLOL	Sandoz Canada, Inc.	02261790	Tablet - Oral	10 MG	4/7/2006
TEVA-PINDOLOL	teva canada limited	00869007	Tablet - Oral	5 MG	12/31/1990
DOM-PINDOLOL	dominion pharmacal	02231650	Tablet - Oral	5 MG	9/17/1998

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access